Detailed studies of GPR35 agonists in comparison to current osteoporosis drugs in mice could provide further evidence for these findings, although such studies would likely need to be performed in mice with humanized GPR35 as most GPR35 agonists have lower potency at mouse GPR35 when compared to human.8 Here, GPR35 is linked to osteoporosis.